VENUS REMEDIES LTD
Q2 FY 2011 RESULTS
Venus Remedies has declared its stand alone results for the Q/E sept,2010.
Net Sales has increased to Rs.857.5 cr from Rs.821.67 in previous qtr (an improvement of 4.36%) and from Rs.748.61 in Q/e Sep,2009 (+14.55%).
Net Profit has increased to Rs.115.65 Cr – up by 5.83% from previous Qtr and by 5.11% from corresponding Q/e sep,2009.
Basic EPS has gone up to Rs.13.62 on a Face value of Rs.10 - up from Rs.12.87 in previous Qtr (+5.83%) and from Rs.12.99 in Q/e Sep,2009(+4.85%)
The Company on October 15, 2010, has allotted 12,00,000 warrants fully convertible into equity shares to Sunev Pharma Solutions Ltd. a promoter group Company on preferential basis.
RESULTS IN FIGURES :
| QTR / End | 30-Sep-10 | 30-Jun-10 | Dif%1 | 30-Sep-09 | Dif%2 |
| Net Sales | 857.5 | 821.67 | 4.36 | 748.61 | 14.55 |
| Other Income | 0.55 | 0.15 | 266.67 | 7.58 | -92.74 |
| Expenditure | -639.09 | -632.01 | 1.12 | -582.85 | 9.65 |
| Interest | -51.13 | -33.63 | 52.04 | -21.06 | 142.78 |
| Profit Befor. Depr.& Tax | 167.83 | 156.18 | 7.46 | 152.28 | 10.21 |
| Depreciation | -23.39 | -19.71 | 18.67 | -19.72 | 18.61 |
| Profit before Tax | 144.44 | 136.48 | 5.83 | 132.56 | 8.96 |
| Tax | -28.79 | -27.2 | 5.85 | -22.53 | 27.79 |
| Net Profit | 115.65 | 109.28 | 5.83 | 110.03 | 5.11 |
| Equity Capital | 84.92 | 84.92 | 0 | 84.73 | 0.22 |
| Basic EPS | 13.62 | 12.87 | 5.83 | 12.99 | 4.85 |
| % of Shares-Public | 74.65 | 74.65 | 0 | 74.59 | 0.08 |
| Opertng Profit Margin | 25.53 | 23.1 | 10.52 | 23.15 | 10.28 |
| Net Profit Margin | 13.49 | 13.3 | 1.43 | 14.7 | -8.23 |
* * * E N D * * *
No comments:
Post a Comment